•
Sep 30, 2012

Jazz Pharmaceuticals Q3 2012 Earnings Report

Total Revenue
$176M
Previous year: $73.3M
+140.1%
EPS
$1.29
Previous year: $0.77
+67.5%
Gross Profit
$143M
Previous year: $69.4M
+105.9%
Cash and Equivalents
$190M
Previous year: $101M
+87.5%
Total Assets
$1.73B
Previous year: $208M
+730.9%

Jazz Pharmaceuticals

Jazz Pharmaceuticals